Celldex Therapeutics buy Cantor Fitzgerald
Start price
27.09.23
/
50%
€25.80
Target price
27.09.24
€51.25
Performance (%)
55.04%
Price
05.09.24
€40.00
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Celldex Therapeutics has seen massive gains of 55.04%. This prediction currently runs until 27.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | 16.279% | 16.279% |
iShares Core DAX® | -1.414% | 7.218% |
iShares Nasdaq 100 | -2.316% | 4.450% |
iShares Nikkei 225® | -2.756% | 10.071% |
iShares S&P 500 | -1.849% | 4.760% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $54.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€35.60
30.07.24
30.07.24
€62.02
30.07.25
30.07.25
10.11%
05.09.24
05.09.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€32.60
18.06.24
18.06.24
€62.32
18.06.25
18.06.25
20.25%
05.09.24
05.09.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€38.80
22.03.24
22.03.24
€61.99
22.03.25
22.03.25
1.03%
05.09.24
05.09.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
64.71%
05.09.24
05.09.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.00
12.10.23
12.10.23
€51.15
12.10.24
12.10.24
60.00%
05.09.24
05.09.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.80
16.08.23
16.08.23
€49.46
16.08.24
16.08.24
12.23%
17.08.24
17.08.24